Nisa Investment Advisors’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$789K Buy
11,969
+506
+4% +$32.2K ﹤0.01% 849
2025
Q4
$728K Sell
11,463
-68
-0.6% -$4.23K ﹤0.01% 908
2025
Q3
$634K Buy
11,531
+1,338
+13% +$55.1K ﹤0.01% 964
2025
Q2
$337K Sell
10,193
-4,606
-31% -$160K ﹤0.01% 1087
2025
Q1
$595K Buy
14,799
+107
+0.7% +$4.92K ﹤0.01% 954
2024
Q4
$691K Sell
14,692
-370
-2% -$19.2K ﹤0.01% 975
2024
Q3
$795K Buy
15,062
+430
+3% +$24K ﹤0.01% 911
2024
Q2
$793K Buy
14,632
+7
+0% +$423 0.01% 938
2024
Q1
$1.03M Sell
14,625
-5,676
-28% -$439K 0.01% 874
2023
Q4
$1.69M Buy
20,301
+11
+0.1% +$398 0.01% 707
2023
Q3
$598K Sell
20,290
-5
-0% -$167 ﹤0.01% 1016
2023
Q2
$662K Buy
20,295
+4,590
+29% +$170K ﹤0.01% 995
2023
Q1
$553K Sell
15,705
-60
-0.4% -$2.45K ﹤0.01% 1038
2022
Q4
$722K Sell
15,765
-100
-0.6% -$4.3K 0.01% 1006
2022
Q3
$755K Buy
15,865
+155
+1% +$7.46K 0.01% 902
2022
Q2
$617K Buy
15,710
+3,500
+29% +$141K 0.01% 979
2022
Q1
$449K Sell
12,210
-2,585
-17% -$91.8K ﹤0.01% 1116
2021
Q4
$491K Buy
14,795
+2,095
+16% +$80.8K ﹤0.01% 1016
2021
Q3
$454 Buy
12,700
+2,080
+20% +$61.2K ﹤0.01% 1148
2021
Q2
$210 Hold
10,620
﹤0.01% 1390
2021
Q1
$247 Buy
10,620
+2,020
+23% +$43.1K ﹤0.01% 1413
2020
Q4
$179K Sell
8,600
-1,350
-14% -$24.7K ﹤0.01% 1515
2020
Q3
$215K Buy
9,950
+2,150
+28% +$50.3K ﹤0.01% 1283
2020
Q2
$184K Buy
7,800
+300
+4% +$5.63K ﹤0.01% 1299
2020
Q1
$88K Hold
7,500
﹤0.01% 1405
2019
Q4
$80K Buy
+7,500
New +$77K ﹤0.01% 1469

Other funds holding CYTK